Misophonia: an imaging study on the neurobiology and the efficacy of cognitive behavioural therapy

Phase 2

Completed

• Conditions: Hatred of sound; 10037176

• Registration Number: NL-OMON35548
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

Symptoms of misophonia
18-65 yrs

Exclusion Criteria

Major Depression
Anxiety disorders
Bipolar disorder
Autism Spectrum Disorders
Psychotic disorders
Epilepsia/CNS disorders

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Main study parameters:<br /><br>- Change in symptom severity as measured with the Amsterdam Misophonia Scale<br /><br>(AMISS) and Clinical Global Impression Scale (CGI)<br /><br>- fMRI<br /><br>- EEG<br /><br>- Neuropsychological paradigms<br /><br>- Genetic outcomes</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Psychiatric questionnaires (HARS, HDRS, IOA, AVL, SCL-90R)</p><br>